Case Study: ALK-Abelló achieves rapid clinical-data overview and meets regulatory deadlines with QlikView (Qlik)

QlikView gave ALK-Abelló a crucial overview

ALK‑Abelló, a global leader in allergy diagnostics and vaccines, needed a fast, reliable way to report complex clinical data for the European Mutual Recognition Procedure for its flagship allergy tablet GRAZAX®. The approval relied on six clinical studies totaling 1,700 patients, and strict 10‑day response deadlines combined with only a few staff able to extract data from Oracle Clinical created a dangerous bottleneck ahead of regulatory review.

A 14‑day QlikView pilot delivered an immediate, easy‑to‑use overview of the clinical database, letting any qualified employee run multidimensional queries (age, gender, pregnancy, combinations) and removing the competence bottleneck. Deployment expanded to about 20 users with plans for company‑wide rollout, produced ROI in 1–2 months, supported multi‑country approvals and reimbursement for GRAZAX®, and helped the product win industry recognition.

ALK-Abello

Lisbet Groes

Director of Biometrics Medical Writing